US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
Patent 11944612 was granted and assigned to Global Blood Therapeutics on April, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 5, 2022
0
Date of Patent
April 2, 2024
0
Patent Applicant
Patent Application Number
17881874
0
Patent Citations
•••
Patent Inventor Names
Athiwat Hutchaleelaha
0
Joshua Eli Lehrer-Graiwer
0
Naveen Bejugam
0
Eleanor L. Ramos
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.